Literature DB >> 17121759

A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy.

S Mangar1, A Thompson, E Miles, R Huddart, A Horwich, V Khoo.   

Abstract

Target localization and verification of the treatment position is important for the accurate delivery of conformal radiotherapy. The bladder in particular is a deformable structure whose shape and position continually varies throughout a course of radiation treatment as a result of bladder filling. We report a novel technique of organ localization using gold seeds as fiducial markers that are implanted into the bladder using a specially adapted applicator that is passed through a rigid cystoscope. The seeds are readily apparent on electronic portal imaging taken at the time of radiotherapy and can thus act as a surrogate for bladder position. The feasibility and technical aspects of performing such a procedure on eight patients were assessed. In all of the patients, some of the seeds were visible on the planning CT scan and remained within the bladder wall throughout the course of radiotherapy treatment. The drop-out rate was minimized by the use of cystodiathermy at the site of seed insertion. It was possible to place the seeds in both areas of normal and diseased bladder tissue. The procedure was associated with minimal toxicity. This technique will form the basis for planning further studies on bladder localization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121759     DOI: 10.1259/bjr/54321311

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  9 in total

1.  A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer.

Authors:  Janice Yeh; Mathias Bressel; Keen Hun Tai; Tomas Kron; Farshad Foroudi
Journal:  Clin Transl Radiat Oncol       Date:  2021-08-06

Review 2.  MR-Guided Adaptive Radiotherapy for Bladder Cancer.

Authors:  Adham Hijab; Boris Tocco; Ian Hanson; Hanneke Meijer; Christina Junker Nyborg; Anders Smedegaard Bertelsen; Robert Jan Smeenk; Gillian Smith; Jeff Michalski; Brian C Baumann; Shaista Hafeez
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

3.  Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance.

Authors:  Daryl Lim Joon; Alexandra Berlangieri; Benjamin Harris; Mark Tacey; Rachel O'Meara; Brent Pitt; Angela Viotto; Kerryn Brown; Michal Schneider; Nathan Lawrentschuk; Shomik Sengupta; Colleen Berry; Trish Jenkins; Michael Chao; Morikatsu Wada; Farshad Foroudi; Vincent Khoo
Journal:  Phys Imaging Radiat Oncol       Date:  2021-02-06

4.  Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes.

Authors:  Muhammad Shahbaz; Asif Ammar; Yuliang Wang; Zeeshan Farhaj; Liang Qiao; Jun Niu
Journal:  Int Braz J Urol       Date:  2021 Jan-Feb       Impact factor: 1.541

5.  A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.

Authors:  Matthew D Greer; Stephanie K Schaub; Stephen R Bowen; Jay J Liao; Kenneth Russell; Jonathan J Chen; Emily S Weg; Juergen Meyer; Tristan Alving; George R Schade; John L Gore; Sarah P Psutka; Robert B Montgomery; Michael Schweizer; Evan Y Yu; Petros Grivas; Jonathan L Wright; Jing Zeng
Journal:  Adv Radiat Oncol       Date:  2021-11-21

6.  The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer.

Authors:  Dominique C van Rooijen; Jeroen B van de Kamer; René Pool; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel
Journal:  Radiat Oncol       Date:  2009-09-24       Impact factor: 3.481

7.  BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.

Authors:  Mischa de Ridder; Lara C Gerbrandy; Theo M de Reijke; Karel A Hinnen; Maarten C C M Hulshof
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

8.  Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.

Authors:  D Whalley; H Caine; P McCloud; L Guo; A Kneebone; T Eade
Journal:  Radiat Oncol       Date:  2015-09-25       Impact factor: 3.481

9.  Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes.

Authors:  Maurice M Garcia; Alexander R Gottschalk; Jonathan Brajtbord; Badrinath R Konety; Maxwell V Meng; Mack Roach; Peter R Carroll
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.